Media Summary: December 7, 2021 UCSD Department of Pharmacology Seminar Series - Fall 2021 Presents: 2025 Stanford Lung Cancer Summit Development of EGFR and ALK Inhibitors for Lung Cancer Speaker: Dr. Broad-MIT Seminars in Chemical Biology March 3, 2025 Broad Institute of MIT and Harvard Speaker:
Nathanael Gray Ph D Challenges - Detailed Analysis & Overview
December 7, 2021 UCSD Department of Pharmacology Seminar Series - Fall 2021 Presents: 2025 Stanford Lung Cancer Summit Development of EGFR and ALK Inhibitors for Lung Cancer Speaker: Dr. Broad-MIT Seminars in Chemical Biology March 3, 2025 Broad Institute of MIT and Harvard Speaker: Session 2 - Chemoproteomics and Covalent Therapeutics Chaired by: Danica Fujimori Dan Nomura Reimagining Druggability ... Targeted protein degradation (TPD) refers to the use of small molecules to induce ubiquitin-dependent degradation of proteins. On July 24, 2026, the Committee will discuss the following bulk drug substances being considered for inclusion on the 503A Bulks ...
